Literature DB >> 15716305

NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration.

Marc J Ruitenberg1, Dane B Levison, Seok Voon Lee, Joost Verhaagen, Alan R Harvey, Giles W Plant.   

Abstract

Adenoviral (AdV) vectors encoding neurotrophin-3 (AdV-NT-3) or the bacterial marker enzyme beta-galactosidase (LacZ gene) were used to transduce olfactory ensheathing glia (OEG) cultures. AdV vector-transduced OEG expressed high levels of recombinant neurotrophin as shown by in situ hybridization and enzyme-linked immunosorbent assay techniques. The biological activity of vector-derived NT-3 was determined in a dorsal root ganglia neurite outgrowth assay. Engineered cell suspensions were then injected into adult Fischer 344 rat spinal cord immediately after unilateral cervical (C4) corticospinal tract (CST) transection. Transplanted animals received a total of 200,000 cells; either non-transduced OEG or OEG transduced with AdV vectors encoding NT-3 or LacZ, respectively. At 3 months after injury, lesion volumes were significantly smaller in all OEG-transplanted rats when compared with control (medium-injected) rats. Anterograde tracing of the lesioned CST projection, originating from the contralateral sensorimotor cortex, showed a significantly greater number of distal CST axons only in OEG-NT-3-transplanted rats. Behavioural analysis was performed on all rats using open field locomotion scoring, and a forelimb reaching task with Eshkol-Wachman movement notation. Analysis of behavioural tests revealed no significant differences in recovery between experimental groups, although movement analysis indicated that possible compensatory mechanisms were occurring after OEG implantation. The results demonstrate that OEG transplantation per se can promote tissue sparing after injury, but, after appropriate genetic modification, these olfactory-derived cells become far more effective in promoting long-distance maintenance/regeneration of lesioned adult CST axons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716305     DOI: 10.1093/brain/awh424

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  21 in total

1.  Ethyl pyruvate promotes spinal cord repair by ameliorating the glial microenvironment.

Authors:  Yimin Yuan; Zhida Su; Yingyan Pu; Xiujie Liu; Jingjing Chen; Feng Zhu; Yanling Zhu; Han Zhang; Cheng He
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Protection of corticospinal tract neurons after dorsal spinal cord transection and engraftment of olfactory ensheathing cells.

Authors:  Masanori Sasaki; Bryan C Hains; Karen L Lankford; Stephen G Waxman; Jeffery D Kocsis
Journal:  Glia       Date:  2006-03       Impact factor: 7.452

Review 3.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

Review 4.  Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury.

Authors:  Ronald Deumens; Elbert A J Joosten; Stephen G Waxman; Bryan C Hains
Journal:  Mol Neurobiol       Date:  2008-04-15       Impact factor: 5.590

5.  Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats.

Authors:  S Rochkind; A Shahar; D Fliss; D El-Ani; L Astachov; T Hayon; M Alon; R Zamostiano; O Ayalon; I E Biton; Y Cohen; R Halperin; D Schneider; A Oron; Z Nevo
Journal:  Eur Spine J       Date:  2005-11-15       Impact factor: 3.134

6.  The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury.

Authors:  Yosuke Ohtake; Dongsun Park; P M Abdul-Muneer; Hui Li; Bin Xu; Kartavya Sharma; George M Smith; Michael E Selzer; Shuxin Li
Journal:  Biomaterials       Date:  2014-03-12       Impact factor: 12.479

Review 7.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

Review 8.  Cell therapy for spinal cord regeneration.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

9.  Use of polyamidoamine dendrimers to engineer BDNF-producing human mesenchymal stem cells.

Authors:  Antos Shakhbazau; Dzmitry Shcharbin; Ihar Seviaryn; Natalya Goncharova; Svetlana Kosmacheva; Mihail Potapnev; Barbara Gabara; Maxim Ionov; Maria Bryszewska
Journal:  Mol Biol Rep       Date:  2009-08-02       Impact factor: 2.316

10.  Brain-derived neurotrophic factor modulation of Kv1.3 channel is disregulated by adaptor proteins Grb10 and nShc.

Authors:  Beverly S Colley; Melissa A Cavallin; Kc Biju; David R Marks; Debra A Fadool
Journal:  BMC Neurosci       Date:  2009-01-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.